1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: ROC analysis: dichotomized favorable outcome (mRS ≤2)^{^a}
Variable AUC P Value 95% CI OOP Sensitivity Specificity
Final infarct (mL) 0.96 <.001 0.91–1.00 29.1 91% 88%
RAPID rCBV core 0.86 .001 0.74–0.96 10.4 85% 78%
RAPID rCBF core 0.81 <.001 0.68–0.93 5.6 73% 72%
RAPID Tmax >4 sec 0.80 <.01 0.65–0.93 146.6 73% 67%
RAPID Tmax >6 sec 0.77 <.01 0.63–0.92 81.9 77% 72%
RAPID Tmax >8 sec 0.76 <.01 0.60–0.91 53.1 77% 72%
RAPID Tmax >10 sec 0.74 <.01 0.58–0.89 26.6 73% 72%
NCCT-ASPECTS 0.72 .01 0.57–0.87 9.5 68% 68%
CBV-ASPECTS 0.75 .01 0.61–0.89 5.0 76% 62%
CBF-ASPECTS 0.72 .02 0.57–0.87 5.0 58% 66%
Clot burden score 0.74 .01 0.59–0.89 6.5 58% 77%
Collateral score^{^b} .72 .20 0.56–0.89 1.5 70% 70%
Note:—OOP indicates optimal operating point, optimal cut-off from ROC analysis for the variable of interest.
↵a Results of ROC analysis relative to dichotomized favorable clinical outcome (90-day mRS ≤2). Performance indicated by ROC AUC in descending-order performance.
↵b Significant relationships were observed for all tested variables, with the exception of the CTA collateral score.